INTRODUCTION {#S1}
============

Genomic instability refers to the accumulation or acquisition of numerical and/or structural abnormalities in chromosomes. It has long been observed that chromosome instability (CIN) is a hallmark of cancer cells and is postulated to be required for tumorigenesis ([@R20], [@R26]). Genomic changes, such as chromosome breaks, translocations, genome rearrangements, aneuploidy, and telomere shortening have been observed in aging organisms ([@R3], [@R11], [@R27], [@R33], [@R38]). Characteristics of genetically unstable cells include structural changes such as insertions, deletions, and translocations, as well as changes in the number of chromosomes (aneuploidy or polyploidy). Cells can gain or lose one or more chromosomes (aneuploidy) or gain part of or an entire genome (polyploidy) ([@R14], [@R20]). Additionally, cells with genomic instability frequently display increased chromosome or chromatid breaks, chromosomal fusions, and centrosome amplification, which itself promotes CIN.

Mechanisms leading to CIN are diverse and incompletely understood. Unrepaired DNA double-strand breaks or eroded telomeres can lead to CIN by serving as substrates for chromosomal fusions and translocations ([@R25]). Amplification of centrosomes may lead to the missegregation of chromosomes and result in aneuploidy ([@R14]). The uncoupling of DNA replication and mitosis can result in polyploidy, which is postulated to be a precursor to aneuploidy ([@R13], [@R14], [@R31], [@R34]). Whether this genomic instability, commonly observed in cancer cells, precedes tumorigenesis or is a by-product of transformation is not clear. However, mice with mutations in genes encoding proteins involved in cell cycle control or DNA damage signaling or repair have increased CIN and many spontaneously develop cancer ([@R16], [@R26]). Therefore maintaining genomic stability appears essential to limit tumorigenesis.

The oncogene Mdm2 is frequently amplified or overexpressed in many human and murine cancers; approximately 10% of all human cancers harbor *MDM2* amplifications ([@R24], [@R28]). Elevated levels of Mdm2 are associated with increased transformation *in vitro* and *in vivo* ([@R24]). Mdm2 is an E3 ubiquitin ligase that functions as a critical negative regulator of the tumor suppressor p53, and Mdm2 can also delay DNA repair through association with a DNA repair complex ([@R4], [@R24]). Mdm2 interferes with the transcriptional activity of p53 by binding to and ubiquitinating p53, targeting it for degradation by the proteosome ([@R24]). Inactivation of p53 function results in a loss of cell cycle checkpoint control and polyploidy, aneuploidy, and tumorigenesis ([@R13], [@R21]). Mdm2 also binds to Nbs1, a protein in the Mre11/Rad50/Nbs1 DNA repair complex, and inhibits DNA double-strand break repair ([@R2], [@R5]). Cells with reduced levels of Nbs1 or that contain mutated Nbs1 have an altered response to DNA damage and are delayed in repairing DNA damage ([@R9], [@R36]). Humans with mutations in *NBS1* frequently develop malignancies ([@R7]). Therefore Mdm2 regulates two proteins essential for monitoring, signaling, and/or repairing DNA damage, which is thought to be a contributing factor to tumorigenesis.

Several studies have linked Mdm2 overexpression to genomic instability through both p53-dependent and p53-independent mechanisms. Overexpression of human Mdm2 in murine fibroblasts that contain wild-type p53 resulted in aneuploidy and centrosome amplification ([@R6]). Recently, loss of p53 was demonstrated to be important for the survival and proliferation of aneuploid cells ([@R13], [@R31], [@R34]). Mammary epithelial cells from mammary specific-*Mdm2* transgenic mice have increased polyploidy, likely due to endoreduplication, and this occurred irrespective of p53 status ([@R23]). Additionally, B-cells from juvenile *Mdm2* transgenic mice, where *Mdm2* expression was driven from its native promoter, have increased chromosome and chromatid breaks and aneuploidy compared to B-cells from wild-type mice ([@R35]). Furthermore, through interaction with Nbs1, Mdm2 overexpression in wild-type or *p53-*null mouse embryonic fibroblasts inhibited DNA double-strand break repair, leading to genomic instability and transformation ([@R2], [@R5]). Thus, elevated expression of Mdm2 is linked to genomic instability, but whether elevated levels of Mdm2 affect chromosomal stability as a mammal ages is unknown. Therefore, we performed an in depth study of the effect of aging alone and together with Mdm2 overexpression on genome stability. We show that specific chromosomal alterations linked to chromosomal instability increase with age, and elevated levels of Mdm2 lead to a greater amount of chromosomal instability that accumulated with age prior to tumor development. The increased numerical and structural chromosome abnormalities in *Mdm2* transgenic mice likely contribute to their increased predisposition to cancer.

RESULTS {#S2}
=======

Chromosome instability increases as mice age {#S3}
--------------------------------------------

To determine the specific effects of aging on overall genome stability and the contribution of increased Mdm2 levels to this process, approximately 3,600 metaphase spreads of splenocytes from 72 littermate-matched pre-cancerous wild-type C57Bl/6 and *Mdm2* hemizygous transgenic mice 2--14 months old were analyzed for chromosomal alterations. (Mice older than 14 months were not evaluated due to the emergence of cancer in the *Mdm2* hemizygous transgenic mice.) The number of chromosomal aberrations, including chromosome and chromatid breaks, chromosome fusions, and metaphases with an abnormal number of chromosomes, were quantified in approximately 50 metaphases from each mouse. There was a small, gradual increase in the total number of chromosomal abnormalities in wild-type mice as they aged ([Fig. 1A and 1B](#F1){ref-type="fig"}). In contrast, *Mdm2* transgenic mice had a marked increase in CIN with increasing age (p\<0.0005). The frequency of chromosomal abnormalities in wild-type and *Mdm2* transgenic mice were similar at 2 months of age, but at 14 months old the number of chromosomal abnormalities in *Mdm2* transgenic mice was twice that in wild-type mice ([Fig. 1B](#F1){ref-type="fig"}). Therefore, as mice age, the frequency of CIN increases, and this is significantly augmented by elevated levels of Mdm2.

Increased chromosome and chromatid breaks in aging mice {#S4}
-------------------------------------------------------

To identify the specific chromosomal alterations that are correlated with aging, and to examine the effects of Mdm2 overexpression on these alterations, we first evaluated chromatid and chromosome breaks from metaphase spreads of splenocytes from pre-cancerous wild-type C57Bl/6 mice and *Mdm2* transgenic littermates. Both chromatid and chromosome breaks were detected in wild-type and *Mdm2* transgenic mice with chromosome breaks dominating in both genotypes ([Fig. 2A--2C](#F2){ref-type="fig"}). The number of metaphases with breaks gradually increased with age for both wild-type and *Mdm2* transgenic mice ([Fig. 2D](#F2){ref-type="fig"}). As we previously reported for splenocytes from mice 3 weeks old ([@R35]), at 2 months old, a higher percentage of metaphases from *Mdm2* transgenic mice had chromosome and chromatid breaks compared to metaphases from wild-type littermates. The mean number of metaphases with DNA breaks was significantly higher for *Mdm2* transgenic mice compared to wild-type mice at all ages evaluated (p=0.001) ([Fig. 2D](#F2){ref-type="fig"}). Moreover, tri-radial chromosomes, which lead to DNA breaks, were detected only in *Mdm2* transgenic cells ([Fig. 2E](#F2){ref-type="fig"}). Surprisingly, the rate of increase of DNA breaks with age was statistically similar between wild-type and *Mdm2* transgenic cells (p=0.49). Therefore, although Mdm2 overexpression increased the frequency of chromosome and chromatid breaks at every age evaluated, Mdm2 overexpression did not accelerate the rate at which breaks occurred with age.

Increased chromosome fusion in cells from *Mdm2* transgenic mice {#S5}
----------------------------------------------------------------

Unrepaired DNA breaks can serve as substrates for genomic rearrangements ([@R25]), which have been found to accumulate in aging mice ([@R11]). Since aging wild-type and *Mdm2* transgenic mice have elevated levels of DNA breaks, we evaluated metaphases for chromosomal fusions from both genotypes of mice at 2--14 months of age. Although fusions were rare, they were identified in both wild-type and *Mdm2* transgenic mice ([Fig. 3A--3C](#F3){ref-type="fig"}). Most (66%) of the fusions identified for both genotypes were centromeric-centromeric fusions also known as Robertsonian translocations ([Fig. 3A & 3B](#F3){ref-type="fig"}), which are known to occur in mice ([@R15]). Centromeric-telomeric fusions accounted for a quarter of the fusions detected ([Fig. 3C](#F3){ref-type="fig"}), and telomeric-telomeric fusions were rare for both genotypes and accounted for less than 10% of the fusions identified. At 2 months of age, wild-type and *Mdm2* transgenic mice had a similar low number of metaphases with fused chromosomes, and both genotypes showed an increase in metaphases with fused chromosomes as the mice aged ([Fig. 3D](#F3){ref-type="fig"}). However, *Mdm2* transgenic mice had a greater percentage of metaphases with fused chromosomes than wild-type mice with the greatest difference detected at older ages (p=0.05) ([Fig. 3E](#F3){ref-type="fig"}). Other deleterious chromosomal fusion abnormalities were only observed in cells from *Mdm2* transgenic mice. Specifically, three chromosomes fused centromere to telomere and a break in one of the fused chromosomes were detected in a metaphase from a 10 month old *Mdm2* transgenic mouse ([Fig. 3F](#F3){ref-type="fig"}). Additionally, a very rare fusion, a ring chromosome, was observed in cells from *Mdm2* transgenic mice as young as 5 months old and in 14 month old mice ([Fig. 3G](#F3){ref-type="fig"}). Therefore, fused chromosomes were more common in *Mdm2* transgenic mice. The prevalence of these abnormalities increased with age in both wild-type and *Mdm2* transgenic mice, but the rate of increase was greater for *Mdm2* transgenic mice, suggesting an interaction between Mdm2 and age on chromosomal fusions. Moreover, severe structurally abnormal chromosomes were only detected in pre-cancerous cells in *Mdm2* transgenics and not in wild-type cells.

Increased polyploid DNA content in cells from aging *Mdm2* transgenic mice {#S6}
--------------------------------------------------------------------------

A cell becomes polyploid by gaining whole sets of chromosomes or an entire genome through a variety of incompletely understood mechanisms ([@R14], [@R20]). The number of chromosomes from metaphases of splenocytes from wild-type and *Mdm2* transgenic mice were quantified to determine the frequency of polyploid cells (near triploid, triploid, near tetraploid, and tetraploid DNA content). Polyploid metaphases (40 chromosomes is normal) were detected in both wild-type and *Mdm2* transgenic mice ([Fig. 4A--4C](#F4){ref-type="fig"}). At two months of age, the number of metaphases with 50--80 chromosomes was similar for wild-type and *Mdm2* transgenic littermates ([Fig. 4C & 4D](#F4){ref-type="fig"}). As the mice aged, the number of metaphases with 50--80 chromosomes significantly increased in *Mdm2* transgenic mice (p=0.04), but remained relatively constant for wild-type mice ([Fig. 4D](#F4){ref-type="fig"}). Furthermore, *Mdm2* transgenic mice also had cells that contained more than 4N DNA ([Fig. 4E](#F4){ref-type="fig"}). Our results indicate that age had little effect on the development of polyploidy in wild-type mice, but elevated levels of Mdm2 significantly increased the rate of emergence of polyploid cells in mice over 14 months. Thus, there was a greater likelihood of gaining partial or whole genomes as mice aged, if Mdm2 was overexpressed.

Elevated rates of aneuploidy in aging *Mdm2* transgenic mice {#S7}
------------------------------------------------------------

Polyploidy is postulated to be a precursor to aneuploidy, which is a loss or gain of whole chromosomes and can result from chromosome missegregation during mitosis ([@R13], [@R14], [@R30], [@R31], [@R34]). The number of chromosomes in metaphases of splenocytes from wild-type and *Mdm2* transgenic littermates of various ages were counted to assess aneuploidy. Metaphases with greater than or less than the normal number of 40 chromosomes were detected in both wild-type and *Mdm2* transgenic mice ([Fig. 5A & 5B](#F5){ref-type="fig"}), but the frequency beyond 2 months of age was different for each ([Fig. 5C & 5D](#F5){ref-type="fig"}). As wild-type mice aged, they showed a small but steady, significant increase in the number of metaphases that were aneuploid ([Fig. 5D](#F5){ref-type="fig"}, p=0.04). Notably, aging *Mdm2* transgenic mice had a large significant, non-linear increase in aneuploid cells such that the mean number of aneuploid cells in mice 14 months old was more than twice that in mice 2 months old (p\<0.0005) ([Fig. 5D](#F5){ref-type="fig"}). Therefore, Mdm2 overexpression appeared to accelerate the rate of aneuploidy development with age compared to wild-type mice.

To assess aneuploidy more in depth, metaphases that lost chromosomes were distinguished from metaphases that gained chromosomes. As mice aged, both wild-type and *Mdm2* transgenic mice had increased numbers of metaphases with less than 40 chromosomes (p=0.003), doubling the mean frequency between 2 months and 14 months of age ([Fig. 6A & 6B](#F6){ref-type="fig"}). Unexpectedly, wild-type and *Mdm2* transgenic mice had a similar number of metaphases with less than 40 chromosomes at all ages evaluated. Consequently, both genotypes of mice showed a similar rate of increase in metaphases with less than 40 chromosomes over 14 months (p=0.88) ([Fig. 6B](#F6){ref-type="fig"}). In contrast, the rate of increase in metaphases with more than 40 chromosomes over 14 months was greater in *Mdm2* transgenic mice than wild-type mice ([Fig. 6C & 6D](#F6){ref-type="fig"}). At 2 months of age there were slightly more metaphases from *Mdm2* transgenic mice that had greater than 40 chromosomes compared to wild-type mice. However, as the mice aged, the number of metaphases with greater than 40 chromosomes slightly increased in wild-type mice, but this increase was not significant (p=0.34). In contrast, the number of metaphases with greater than 40 chromosomes profoundly increased with age in *Mdm2* transgenic mice and was statistically significant (p=0.003) ([Fig. 6D](#F6){ref-type="fig"}). *Mdm2* transgenic mice had triple the mean number of metaphases with greater than 40 chromosomes at 14 months old compared to at 2 months of age. These data indicate that as wild-type and *Mdm2* transgenic mice age, both gains and losses of chromosomes increased. However, Mdm2 overexpression only resulted in an exacerbation of the rate of gains in chromosomes and not in the loss of chromosomes.

DISCUSSION {#S8}
==========

Genomic instability is characterized by chromosomal alterations, including changes in the number of chromosomes (aneuploidy or polyploidy) and/or in the structure of chromosomes (breaks, fusion, insertions, deletions, and translocations) ([@R20], [@R26]). Limited published studies suggest that genome instability increases with age in mammals ([@R3], [@R27], [@R33], [@R38]). The incidence of cancer increases with age, and cancer cells commonly have genome instability, but the contribution chromosomal aberrations make to the development of malignancies is incompletely understood. This study shows that specific numerical and structural chromosomal changes increased with age in wild-type C57Bl/6 mice and were exacerbated with Mdm2 overexpression. Importantly, all chromosomal alterations in both wild-type and *Mdm2* transgenic mice occurred prior to overt tumor development, indicating genome instability precedes tumorigenesis and likely contributes to the development of tumors. Moreover, *Mdm2* transgenic mice had greatly increased and more severe chromosomal alterations than wild-type mice that correlated to age; they also develop cancer significantly earlier in life than wild-type mice, which may never develop a malignancy. Therefore, our data from approximately 3,600 metaphases from 72 littermate-matched mice from 2 to 14 months old provide new insight into aging and the types of chromosomal alterations associated with it that may lead to tumorigenesis.

Polyploidy is considered a prerequisite to aneuploidy ([@R13], [@R14], [@R30], [@R31], [@R34]), which did increase and was correlated with age in wild-type mice. Therefore, it was expected that polyploid frequency would increase with age in wild-type cells. However, we did not detect an increase in polyploid cells in aging wild-type mice, suggesting that this genetic abnormality is not linked to age up to 14 months old. Alternatively, many of the polyploid cells that did emerge in the wild-type mice may not have survived and were, therefore, not detected, since other genetic alterations, such as loss of functional p53, appear required for polyploid cell survival ([@R22], [@R30]). Notably, *Mdm2* transgenic mice had both increased polyploid and aneuploid cells that correlated with age. *Mdm2* transgenic mice possessed cells with elevated levels of near triploid to true tetraploid DNA content and also had cells that had greater than 4N DNA. Since Mdm2 negatively regulates p53 ([@R24]), and p53 inhibits the development of tetraploidy ([@R13], [@R14], [@R30], [@R31], [@R34]), the polyploidy we observed in *Mdm2* transgenic cells is likely due at least in part to inhibition of p53 by Mdm2. Moreover, Mdm2 expression can lead to the degradation of the p53 transcriptional target gene and cell cycle inhibitor p21, and loss of p21 results in endoreduplication and polyploid cells ([@R18], [@R29]). In addition, Mdm2 also negatively regulates the DNA repair protein, Nbs1 ([@R2], [@R5]). Nbs1 has a role in preventing endoreduplication ([@R37]), which leads to polyploidy, suggesting that Mdm2 may influence polyploidy through the regulation of Nbs1 as well. Therefore, there are multiple pathways to tetraploidy mediated by Mdm2 expression to explain the increased polyploidy in *Mdm2* transgenic mice.

Aneuploidy frequently arises due to defects in chromosome segregation during mitosis ([@R31]). Recently, loss of p53 function was found to be important for the proliferation of aneuploid cells ([@R32]), which provides an explanation for the increased number of aneuploid cells in *Mdm2* transgenic mice over that in wild-type mice. Interestingly, overexpression of Mdm2 resulted in an increase in all measures of genome instability, except the loss of chromosomes. Surprisingly, the number of cells losing one or more chromosomes increased at a similar rate with age in both wild-type and *Mdm2* transgenic mice. In contrast, Mdm2 overexpression led to a greater frequency of gains of chromosomes compared to the rate in wild-type mice, and this increased with age. It is currently unknown why Mdm2 overexpression would influence a gain but not a loss in chromosome number; however, it is possible that Mdm2 preferentially affects endoreduplication events rather than chromosome missegregation events. Alternatively, a cell may only be able to sustain the loss of certain chromosomes, or require the acquisition of additional genetic alterations to survive the loss of chromosomes.

DNA breaks can be substrates for fusions and translocations of chromosomes ([@R25]), which can accumulate in aging mice ([@R11]). Previously we reported that Mdm2 overexpression in primary fibroblasts results in an Nbs1-dependent delay in DNA double-strand break repair, resulting in DNA breaks persisting longer and an increase in chromatid and chromosome breaks ([@R2], [@R5]). Unexpectedly, the rate of increase in chromatid and chromosome breaks in aging mice was similar between wild-type and *Mdm2* transgenics, although *Mdm2* transgenic cells had more DNA breaks than their wild-type littermates at every age evaluated. Moreover, tri-radial chromosomes, which are usually due to increased mitotic recombination, were observed in *Mdm2* transgenic mice, but not in wild-type mice. Tri-radial chromosomes frequently lead to DNA breaks during the next round of cell cycle. In accordance with the rate of breaks, there was an increase in chromosomal fusions that correlated with age in both the wild-type and the *Mdm2* transgenic mice. Notably, Mdm2 overexpression resulted in severe structural chromosome fusion abnormalities that were not observed in wild-type mice. Metaphases with multiple chromosomes fused end-to-end and ring chromosomes were detected in *Mdm2* transgenic mice as young as 5 months old. The chromosomal structure of three chromosomes fused centromere to telomere is typical of a breakage-fusion-bridge cycle that can lead to gene amplifications or translocations and is associated with tumorigenesis ([@R8]). Thus, elevated expression of Mdm2 over time increased fusion events, which may be due to the increase in total overall breaks in the cells of these mice, but may also be due to other uncharacterized mechanisms.

The mechanisms of how genome instability increases with age are unclear, although a decrease in the efficiency of DNA repair and apoptotic pathways, which lead to cells surviving DNA damage and possibly producing progeny, are likely causes. Studies using a variety of techniques have shown age-related changes in DNA repair mechanisms ([@R17]). Specifically, the expression and activity of DNA repair enzymes decrease with age. For example, signaling from the DNA damage kinase, ATM, and the response of other DNA repair proteins declines with age ([@R12], [@R17]). Similarly, there is a decrease in p53 function with age ([@R12]). A reduction in ATM and p53 function results in decreased DNA repair, reduced apoptosis, and an increase in CIN and tumorigenesis ([@R26]). Mdm2 negatively regulates both p53 and mediators of ATM activation, the Mre11/Rad50/Nbs1 DNA repair complex ([@R2], [@R5], [@R24]). Thus, Mdm2 overexpression should both induce and allow chromosomal aberrations to accumulate in cells over the course of a lifetime, ultimately leading to cellular transformation and tumorigenesis. We previously showed that in primary B cells in young mice, Mdm2 overexpression leads to an increase in DNA breaks and aneuploidy ([@R35]). Here our data reveal that prolonged Mdm2 overexpression worsens the genomic abnormalities observed over time, and that chromosomal alterations accumulate with age prior to tumor development. Moreover, the increased CIN correlates to an increased tumor incidence in the *Mdm2* transgenic mice. It will be important in the future to further characterize the genomic alterations that arise as an organism ages and determine the contribution of specific alterations to tumorigenesis.

METERIALS AND METHODS {#S9}
=====================

Mice {#S10}
----

*Mdm2* transgenic mice (from Dr. Steve Jones; U Mass) that express the *Mdm2* transgene under the control of its native promotor ([@R19]) were backcrossed over ten generations to generate congenic C57Bl/6 mice. Experimental mice were generated by breeding hemizygous *Mdm2* transgenic males to C57Bl/6 females to generate hemizygous *Mdm2* transgenic mice and wild-type littermate controls. *Mdm2* transgenic mice and non-transgenic littermate matched controls were sacrificed at specific ages. Mice greater than 14 moths old were excluded from the study due to tumor development in *Mdm2* transgenic mice. Tissues from each mouse were carefully evaluated for malignancies; any mouse with overt cancer or suspected of having a malignancy were excluded from the study. All mice in this study conformed to institutional, state and federal rules and regulations.

Chromosome analysis {#S11}
-------------------

Spleens were harvested from *Mdm2* transgenic mice and littermate matched wild-type controls at 2, 5, 8, 10, 12, and 14 months old. Splenocytes were stimulated to mitosis by cultivation for 48 hours in RPMI-1640 supplemented with L-glutamine, 10% fetal bovine serum, 0.5% β-mercaptoethanol, 3μg/ml lipopolysaccharide (LPS), and 5μg/ml concavalin A. Colcemid (1:100 dilution, KaryoMAX, Gibco) was added for an additional 4 hours. Cells were harvested and metaphase spreads were prepared by standard procedures. Chromosomes were stained with propidium iodide (PI) (Sigma, St. Louis, MO) and 4′, 6′-diamidino-2-phenyl-indo-dihydrochloride (DAPI) (Sigma). Slides were mounted with Vectashield (Vector Laboratories, Burlingame, CA), blinded, and 48--52 metaphases for each mouse for each genotype for each age were visualized and then photographed with a CCD camera coupled with fluorescent microscopy (Nikon, Eclipse 80*i*, Melville, NY, USA) using MetaMorph software (Molecular Devices Corp., Sunnyvale, CA). The type and number of chromosomal abnormalities were counted in each image. Only breaks visible by both PI and DAPI staining were scored as a break. The number of chromosomes was quantified in each image with Image Tool (UTHSCSA, TX).

Statistical Methods {#S12}
-------------------

The effects of age and genotype on the total number of chromosome abnormalities were assessed using multiple linear regression. The number of abnormalities per mouse was regressed on their genotype and age at sacrifice. An interaction term between genotype and age at sacrifice was included in this model. Negative binomial regression was used to model the event rates (the proportion of metaphase cells with the genetic abnormality of interest) in terms of genotype and age at sacrificed was performed ([@R1]). The logarithm of the number of evaluated cells in metaphase from each mouse was included as an offset in our models. An interaction term between genotype and age was also included in these models whenever there was evidence that the multiplicative model might be false. Likelihood ratio tests of over-dispersion were performed for all models. Wald tests were used to evaluate how event rates varied with age and genotype. Estimates of the expected event rates shown in [Figures 1B](#F1){ref-type="fig"}, [2D](#F2){ref-type="fig"}, [3E](#F3){ref-type="fig"}, [4D](#F4){ref-type="fig"}, [5D](#F5){ref-type="fig"}, [6B](#F6){ref-type="fig"}, and [6D](#F6){ref-type="fig"} were derived from these models. These data were also analyzed using general estimating equations (GEE) models with a logarithmic link function and a binomial random component ([@R10]). The Huber-White sandwich estimator was used in these analyses to adjust the variance-covariance matrix of the models' parameter estimates. These models gave results that were very similar to those obtained from our negative binomial regression models. The results given in this manuscript are from our negative binomial models.
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![Increased chromosomal instability with age. Metaphases from splenocytes from wild-type or littermate matched *Mdm2* transgenic mice ages 2--14 months old were evaluated for chromosomal abnormalities (e.g., breaks, fusions, altered number of chromosomes). A) The number of chromosomal abnormalities of each mouse at each age is plotted. Each symbol represents an individual mouse, and the mean value for each genotype at each age is denoted by a black line. B) The expected number of chromosomal abnormalities at each age is given by a solid (wild-type) or dashed (transgenic) line. The mean number of chromosomal abnormalities of each genotype at each age is represented by symbols.](nihms286985f1){#F1}

![Chromosome and chromatid breaks increase with age. Metaphases from splenocytes from wild-type or littermate matched *Mdm2* transgenic mice ages 2--14 months old were evaluated for chromosome or chromatid breaks. A & B) Representative pictures of chromatid (A) and chromosome (B) breaks. Arrows point to breaks. Insert in the corner of each photograph is the chromosome with the break. C) The percentages of metaphases with chromosome or chromatid breaks from each mouse are shown; each symbol represents an individual mouse. A black line denotes the mean percentage for each genotype at each age. D) The expected percentage of cells with chromosome or chromatid breaks is denoted by a solid (wild-type) or a dashed (transgenic) line. The mean percentages of each genotype at each age are represented by symbols. E) A picture of a metaphase from an *Mdm2* transgenic mouse with a tri-radial chromosome (arrow points to defect).](nihms286985f2){#F2}

![Mdm2 overexpression increases chromosome fusion frequency as mice age. Metaphases from splenocytes from wild-type or littermate matched Mdm2 transgenic mice ages 2--14 months old were evaluated for chromosome fusions. A--C) Representative pictures of centromere-centromere (A & B) and telomere-centromere (C) fusions. Arrows point to fusions. D) The percentages of metaphases with fusions for each mouse are shown; each symbol represents an individual mouse. The mean values of each genotype at each age are denoted by a black line. E) Plots of the expected percentage of cells with fusions at each age are denoted by a solid (wild-type) or a dashed (transgenic) line. The mean values of each genotype at each age are represented by symbols. F--G) Severe structural chromosomal abnormalities in *Mdm2* transgenic cells. F) A picture of a metaphase with three chromosomes fused centromere to telomere and a break in one of the chromosomes. Arrow points to defect. G) Metaphase with a ringed chromosome. Arrow points to ring.](nihms286985f3){#F3}

![Mdm2 overexpression induces polyploidy that increases with age. Chromosome number from metaphases from splenocytes from wild-type or littermate matched *Mdm2* transgenic mice ages 2--14 months old were counted. A--B) Representative pictures of metaphases with near triploidy (A) and near tetraploidy (B). Numbers of chromosomes in each metaphase are indicated. C) The percentages of metaphases with 50--80 chromosomes for each mouse are shown; each symbol represents an individual mouse. A black line denotes the mean percentage for each genotype at each age. D) Plots of the expected percentage of polyploidy cells are denoted by a solid (wild-type) or a dashed (transgenic) line. The mean values of each genotype at each age are represented by symbols. E) A representative picture of a metaphase from an *Mdm2* transgenic mouse with greater than 4N DNA content.](nihms286985f4){#F4}

![Increased aneuploid cells in aging *Mdm2* transgenic mice. Chromosome number from metaphases of splenocytes from wild-type or littermate matched *Mdm2* transgenic mice ages 2--14 months old were counted. A & B) Representative pictures of cells with less than 40 chromosomes (A) and more than 40 chromosomes (B). Numbers of chromosomes in each metaphase are indicated. C) Plots of the percentage of aneuploid metaphases from each mouse; each symbol represents an individual mouse. The mean values of each genotype at each age are denoted by a black line. D) The expected percentage of cells at each age is denoted by a solid (wild-type) or a dashed (transgenic) line. The mean values of each genotype at each age are represented by symbols.](nihms286985f5){#F5}

![*Mdm2* transgenic mice have a significant gain in chromosomes as they age. Metaphases of splenocytes from wild-type or littermate matched *Mdm2* transgenic mice ages 2--14 months old were evaluated for chromosome number. A--D) Data for the loss of chromosomes (A & B) or the gain of chromosomes (C & D) for both genotypes of mice. A & C) Percentages for each mouse are shown; each symbol represents an individual mouse. A black line denotes the mean percentage for each genotype at each age. B & D) Plots of the expected percentage of cells with a loss (B) or a gain (D) of chromosomes are denoted by a solid (wild-type) or a dashed (transgenic) line. The mean values of each genotype at each age are represented by symbols.](nihms286985f6){#F6}
